Aug 2026· Proceedings of the 32nd ACM SIGKDD Conference on Knowledge Discovery and Data Mining V.2· pp. 12207-12218· 0 citations· 40 references
TL;DR
RxGuard is a novel decision-oriented framework that formulates medication combination recommendation as utility maximization under explicit feasibility constraints and improves both recommendation performance and safety, while providing consistent, decision-aligned auditing.
Abstract
Medication combination recommendation predicts a set of medications for a patient visit from longitudinal electronic health records (EHRs) and is safety-critical, since feasibility depends on set-level constraints such as drug--drug interactions (DDIs). Despite substantial progress, existing approaches suffer from three limitations: (1) safety is often imposed as a training-time soft regularizer, while inference relies on thresholding or top-k selection over independent drug scores, providing no executable per-instance feasibility control; (2) external knowledge is mainly used for representation enrichment rather than being compiled into inference-ready decision artifacts that directly support constraint execution and evidence retrieval; and (3) explanations are typically inclusion-centric, lacking structured, auditable rationales for constraint-triggered exclusions. To address these gaps, we propose RxGuard (Rx denotes prescription), a novel decision-oriented framework that formulates medication combination recommendation as utility maximization under explicit feasibility constraints. Technically, RxGuard learns trajectory-aware medication utilities and a candidate set from EHRs, compiles external knowledge into an executable feasibility interface and an Evidence KG for audit retrieval, and performs guarded set selection at inference time to enforce feasibility by construction while producing decision-consistent audit records with grounded rationales for both inclusions and exclusions. Experiments on MIMIC-III and MIMIC-IV demonstrate that RxGuard improves both recommendation performance and safety, while providing consistent, decision-aligned auditing.
SpecTD-MR, a novel medication recommendation framework for Disease Spectrum-aware and Time-evolving Dependency Learning, is proposed that surpasses state-of-the-art baselines in accuracy, while providing visualizable structural associations to support insights into dynamic disease evolution.
Yi-Shuo Li, Cong Wang, Shou-Jin Wang et al.· ACM Transactions on Informat...· 1 citation
RTSANet is proposed, which integrates inter-visit drug similarity and external adverse drug reaction information, and captures medication relationships across visits, enhances drug representations with safety-related knowledge, and generates more accurate and safer medication combinations.
Yuan-Yuan Zhang, Zhen-Nuo Wang, Shuang Du et al.· Computer Methods in Biomecha...· 0 citations
Accurate medication recommendation is central to clinical decision-making, directly determining therapeutic efficacy and patient safety. However, existing methods suffer from two key limitations: drugs are often abstracted as discrete tokens, ignoring their molecular structures and pharmacological mechanisms, and the c...
Jun-Ke Wang, Hong-Shun Ling, Li Zhang et al.· 0 citations
Across a European non-interactive multimorbidity benchmark, an Asian interactive multimorbidity benchmark, and an Asian non-interactive cross-guideline benchmark, ATLAS achieves the strongest complete-decision performance among the compared systems.
Zihan Wang, Ang-Lin Liu, Rong Wang et al.· 0 citations
Longitudinal electronic health records (EHRs) capture years of patient history across notes, codes, labs, and procedures, and contain evidence needed to reason about likely clinical outcomes. However, comprehensive clinician review of these records is impractical, and LLM-based processing is costly and often unreliable...
Feng-Nan Li, Heman Burre, Li-Wen Sun et al.· 0 citations
DynMedRec captures fine-grained drug information by modeling the interactions between substructures and employing a clinical-context query mechanism to generate adaptive molecular representations, and integrates structural correlations among medical codes to enhance visit-level patient representations.